Biostage Inc.

Biostage Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.56
Market Cap
$15.01 M
Shares Outstanding
6.67 M
Public Float
1.36 M

Profile

Address
84 October Hill Road
Holliston Massachusetts 01746
United States
Employees -
Website http://www.biostage.com
Updated 07/08/2019
Biostage, Inc. is a biotechnology company, which engages in the development of organ implants to treat congenital defects, cancers, and life-threatening conditions of the esophagus, bronchus and trachea. It operates through Cellframe technology, engineered to stimulate the body's signaling pathways and natural healing process to regenerate and restore organ function. The company was founded on May 3, 2012 and is headquartered in Holliston, MA.

Financials

View All

Jason Jing Chen
Chairman
James J. McGorry
Chief Executive Officer & Independent Director